1.
L Vazquez, MP Encinas, LS Morin, P Vilches, N Gutierrez, R Garcia-Sanz, D Caballero, AD Hurle. Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients. haematol [Internet]. 1999Mar.1 [cited 2024Mar.28];84(3):231-6. Available from: https://haematologica.org/article/view/1321